MYSTERY-HF: Myeloperoxidase Inhibition in Patients With Heart Failure and Reduced Ejection Fraction: A Phase II Randomized Controlled Trial

Simon Braumann

Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine (S. Braumann, S.M.-M., S.R., S.G., S. Baldus), University of Cologne, Germany.

Sascha Macherey-Meyer

Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine (S. Braumann, S.M.-M., S.R., S.G., S. Baldus), University of Cologne, Germany.

Amin Polzin

University Hospital Düsseldorf, Düsseldorf, Germany

Angelika Costard-Jäckle

Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center North Rhine-Westphalia, University Hospital of the Ruhr-Universität Bochum, Germany (A.C.-J.).

Caroline Morbach

Bernhard Haring

Harald Lapp

Department of Cardiology, Heart Center, Zentralklinik Bad Berka, Germany (H.L.).

Vincent Ten Cate

Preventive Cardiology and Preventive Medicine, Department of Cardiology, University Medical Center of the Johannes Gutenberg-University Mainz, Germany (V.t.C., A.G., P.S.W.).

Alexander Gieswinkel

University Medical Center of the Johannes Gutenberg University Mainz, Germany, Mainz, Germany

Jithmi Weliwitage

Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne (J.W., M.H.), University of Cologne, Germany.

Martin Hellmich

Erik Michaëlsson

Karin Nelander

Cardiovascular, Renal and Metabolism Biometrics, Late Cardiovascular, Renal and Metabolism (K.N.), BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.

Nelli Ens-Jäger

Coordinating Center for Clinical Trials, Philipps-Universität Marburg, Germany (N.E.-J.).

Stephan Rosenkranz

Materials Science Division

Simon Geißen

Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine (S. Braumann, S.M.-M., S.R., S.G., S. Baldus), University of Cologne, Germany.

Norbert Frey

P. Christian Schulze

University Hospital Jena, Friedrich-Schiller-University, Jena, Germany

Malin Aurell

Early Clinical Development, Research and Early Clinical Development, Cardiovascular, Renal and Metabolism (E.M., M.A.), BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.

Michael Böhm

Stefan Frantz

Malte Kelm

Volker Rudolph

Sanjiv J. Shah

Northwestern University Feinberg School of Medicine, Chicago

Philipp S. Wild

Stephan Baldus